[swift-template name="issuu-popup"]
Isotope Production
From the first discovery of isotopes about a century ago, scientists have studied their benefits. Today, they impact industry, agriculture, archaeology, mining, power generation, and medicine. They have a prominent place in today’s world. All matter in the universe is comprised of elements, made up of protons, neutrons and electrons. Isotopes have extra neutrons which can make them unstable, causing them to give off energy. Those energized radioisotopes can occur naturally, or be created artificially by irradiating a stable element in a particle accelerator or a nuclear reactor like the ones at Bruce Power.
Isotope Production at Bruce Power
The Isotope Production System at Bruce Power is the first commercial nuclear reactor in the world that produces lutetium-177 (Lu-177). Lu-177 is an example of a theranostic, which means it can be used for both therapy and diagnosis of medical conditions like prostrate and neuroendocrine cancer.
Lu-177 is used to both diagnosis and treat prostate cancer and neuroendocrine tumors.
Lu-177 allows for targeted and precise treatments, destroying cancer cells while limiting damage to surrounding healthy tissues and organs. By supporting production and marketing of Lu-177, the Gamzook’amin aakoziwin partnership has created unmatched capacity to provide a redundant and reliable supply of Lu-177. This will improve access to more cancer-fighting Lu-177 treatments
Recovered recycled target material is decayed for use in a subsequent irradiation.
Lutetium-177
The Isotope Production System at Bruce Power is the first commercial nuclear reactor in the world that produces lutetium-177 (Lu-177). Lu-177 is an example of a theranostic, which means it can be used for both therapy and diagnosis of medical conditions like prostrate and neuroendocrine cancer.
Lu-177 is used to both diagnosis and treat prostate cancer and neuroendocrine tumors.
Lu-177 allows for targeted and precise treatments, destroying cancer cells while limiting damage to surrounding healthy tissues and organs. By supporting production and marketing of Lu-177, the Gamzook’amin aakoziwin partnership has created unmatched capacity to provide a redundant and reliable supply of Lu-177. This will improve access to more cancer-fighting Lu-177 treatments
